Division of Lipid Science and Technology, Indian Institute of Chemical Technology, Hyderabad 500 007, India.
Biomaterials. 2012 Sep;33(26):6220-9. doi: 10.1016/j.biomaterials.2012.05.006. Epub 2012 May 31.
Dendritic cells (DCs) pulsed/transduced with tumor-associated or viral antigens have shown promise in combating cancer and infectious diseases. Despite significant progresses, development of a biologically safe DC-based genetic immunization (DNA vaccination) system capable of providing truly long-lasting protective immunity remains a significant scientific challenge. Here we show that immunization with autologous DCs pre-transfected with electrostatic complexes (lipoplexes) of a plasmid DNA encoding melanoma tumor associated antigen and liposomes of two lysinylated cationic amphiphiles with mannose-mimicking quinic and shikimic acid head-groups provides long-lasting (300 days post tumor challenge) protective immunity with significant memory response (more than six months after the second tumor challenge) in more than 80% immunized mice. The presently described non-viral ex vivo DC-transfection system may be exploited in inducing long-lasting immune response in DC-based genetic immunization.
树突状细胞(DCs)经肿瘤相关或病毒抗原脉冲/转导后,在抗击癌症和传染病方面显示出巨大的潜力。尽管取得了重大进展,但开发一种具有生物安全性的基于树突状细胞的基因免疫(DNA 疫苗接种)系统,能够提供真正持久的保护性免疫,仍然是一个重大的科学挑战。在这里,我们证明了用编码黑色素瘤肿瘤相关抗原的质粒 DNA 的静电复合物(脂质体)预先转染的自体树突状细胞进行免疫接种,并与两种赖氨酸化阳离子两亲物的脂质体联合使用,这些两亲物带有甘露糖模拟的奎宁酸和莽草酸头部基团,可在 80%以上的免疫小鼠中提供长达 300 天(肿瘤挑战后)的持久(超过 6 个月后的第二次肿瘤挑战)保护性免疫和显著的记忆反应。目前描述的非病毒体外 DC 转染系统可用于诱导基于树突状细胞的基因免疫中的持久免疫反应。